戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 c neuromuscular junction disorder resembling Lambert-Eaton myasthenic syndrome.
2  diseases, such as diabetes mellitus and the Lambert-Eaton myasthenic syndrome.
3 ome, dermatomyositis, myasthenia gravis, and Lambert-Eaton myasthenic syndrome.
4 ved in an autoimmune neuromuscular disorder, Lambert-Eaton myasthenic syndrome.
5 ion sometimes occurs in association with the Lambert-Eaton myasthenic syndrome.
6 s developed electrophysiologically confirmed Lambert-Eaton myasthenic syndrome.
7 eatment for neuromuscular weakness caused by Lambert-Eaton myasthenic syndrome.
8 ved in the autoimmune neuromuscular disorder Lambert-Eaton myasthenic syndrome.
9 ption of the opsoclonus-myoclonus ataxia and Lambert-Eaton myasthenic syndromes.
10  limbic encephalitis, 3 cerebellar ataxia, 2 Lambert-Eaton myasthenic syndrome, 1 autonomic neuropath
11 and demonstrated an autoimmune basis for the Lambert Eaton myasthenic syndrome and 'seronegative' mya
12                                              Lambert Eaton myasthenic syndrome and acquired neuromyot
13 d GV-58 in a passive transfer mouse model of Lambert-Eaton myasthenic syndrome and have shown that we
14 ced improvement in several patients with the Lambert-Eaton myasthenic syndrome and myasthenia gravis
15                       Some syndromes such as Lambert-Eaton myasthenic syndrome and neuromyotonia are
16 ataxia type 2, spinocerebellar ataxia 6, and Lambert-Eaton myasthenic syndrome), and the skeletal mus
17 ciated with Waldenstrom's macroglobulinemia, Lambert-Eaton myasthenic syndrome, and multifocal motor
18 nase antibody-positive myasthenia gravis and Lambert-Eaton myasthenic syndrome are about 20 times les
19                        Myasthenia gravis and Lambert-Eaton myasthenic syndrome are antibody-mediated
20  predict the course of myasthenia gravis and Lambert-Eaton myasthenic syndrome are needed.
21                  Some disorders, such as the Lambert-Eaton myasthenic syndrome, are effectively treat
22 ations, although 1 developed a fatal case of Lambert Eaton myasthenic syndrome following ICI treatmen
23 ation patients without clinically identified Lambert-Eaton myasthenic syndrome had P/Q-type voltage-g
24 ubtype that is targeted by antibodies in the Lambert-Eaton myasthenic syndrome has been identified, a
25                                              Lambert-Eaton myasthenic syndrome IgG did not selectivel
26                     Incubation of cells with Lambert-Eaton myasthenic syndrome IgG for 24 to 48 hours
27 iated with small-cell lung cancer, including Lambert-Eaton myasthenic syndrome (LEMS) and paraneoplas
28                   Myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) are autoimmune
29                                              Lambert-Eaton myasthenic syndrome (LEMS) is a paraneopla
30                                              Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmun
31                                              Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmun
32 d/or signs were present in 18 of 23 (78%) of Lambert-Eaton myasthenic syndrome (LEMS) patients evalua
33                To evaluate the Dutch-English Lambert-Eaton Myasthenic Syndrome (LEMS) Tumour Associat
34                                           In Lambert-Eaton myasthenic syndrome (LEMS), SOX antibodies
35 t underlie muscle weakness in the autoimmune Lambert-Eaton myasthenic syndrome (LEMS).
36 tonomic symptoms characterize the autoimmune Lambert-Eaton myasthenic syndrome (LEMS).
37 thenic syndrome and have shown that weakened Lambert-Eaton myasthenic syndrome-model neuromuscular sy
38 t, some PNSs such as sensory neuronopathy or Lambert-Eaton myasthenic syndrome rarely occur in lympho
39 lastic cerebellar degeneration, but improved Lambert-Eaton myasthenic syndrome symptoms.
40 ia gravis can be associated with thymoma and Lambert-Eaton myasthenic syndrome with small-cell lung c